Cargando…
BRDT promotes ovarian cancer cell growth
Bromodomain testis-specific factor (BRDT) is a member of the bromodomain and extra-terminal (BET) family proteins. Its expression and potential functions in ovarian cancer were examined. We show that BRDT is overexpressed in human ovarian cancer tissues and in established (CaOV3)/primary ovarian can...
Autores principales: | Chen, Ling, Cai, Shang, Wang, Jing-mei, Huai, Ying-ying, Lu, Pei-Hua, Chu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705741/ https://www.ncbi.nlm.nih.gov/pubmed/33257688 http://dx.doi.org/10.1038/s41419-020-03225-y |
Ejemplares similares
-
The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice: A novel inhibition of BRDT for male contraception
por: Wu, Sixian, et al.
Publicado: (2022) -
Small-Molecule Inhibition of BRDT for Male Contraception
por: Matzuk, Martin M., et al.
Publicado: (2012) -
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma
por: Wan, Pei, et al.
Publicado: (2020) -
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT
por: Yu, Zhifeng, et al.
Publicado: (2021) -
Whole-exome sequencing identified a homozygous BRDT mutation in a patient with acephalic spermatozoa
por: Li, Lin, et al.
Publicado: (2017)